Development Level

Tbio 4 | 10,625
Tdark 2 | 7,003

IMPC Phenotype

abnormal eye morphology 1 | 38
abnormal eye size 1 | 11
embryonic lethality prior to o... 1 | 148
embryonic lethality prior to t... 1 | 187
microphthalmia 1 | 15

Disease

ovarian cancer 4 | 8,491
atypical teratoid / rhabdoid tumor 3 | 4,369
glioblastoma 3 | 5,572
medulloblastoma, large-cell 3 | 6,234
osteosarcoma 3 | 7,933
Alzheimer's disease 2 | 644
Breast cancer 2 | 3,098
breast carcinoma 2 | 1,614
cystic fibrosis 2 | 1,670
diabetes mellitus 2 | 1,663
ependymoma 2 | 2,514
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,714
medulloblastoma 2 | 1,524
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
primary pancreatic ductal adenocarcinoma 2 | 1,271
psoriasis 2 | 6,685
spina bifida 2 | 1,064
subependymal giant cell astrocytoma 2 | 2,287
Cancer 1 | 2,346
Cowpox 1 | 15
Duchenne muscular dystrophy 1 | 602
Gout 1 | 93
IGA Glomerulonephritis 1 | 454
Inflammation 1 | 109
Lupus erythematosus 1 | 80
Mammary Neoplasms 1 | 410
Multiple myeloma 1 | 1,327
Nemaline myopathy 1 | 17
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Nephrolithiasis 1 | 31
Neutropenia 1 | 78
Osteoporosis 1 | 259
Polycystic Ovary Syndrome 1 | 334
Precancerous Conditions 1 | 69
Rheumatoid Arthritis 1 | 1,170
Squamous cell carcinoma of esophagus 1 | 82
Thrombocytopenia 1 | 105
Tularemia 1 | 22
Wiskott-Aldrich syndrome 1 | 27
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 499
carotid artery thrombosis 1 | 6
chronic lymphosyte leukemia 1 | 232
colon cancer 1 | 1,475
cutaneous lupus erythematosus 1 | 1,056
esophageal adenocarcinoma 1 | 737
group 3 medulloblastoma 1 | 2,254
group 4 medulloblastoma 1 | 1,875
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 550
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
juvenile dermatomyositis 1 | 1,189
lung cancer 1 | 4,473
malignant mesothelioma 1 | 3,163
mucosa-associated lymphoid tissue lymphoma 1 | 480
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
pancreatic carcinoma 1 | 567
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
posterior fossa group B ependymoma 1 | 1,530
primary Sjogren syndrome 1 | 788
primitive neuroectodermal tumor 1 | 3,031
sarcoidosis 1 | 368
tuberculosis 1 | 1,563
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 6 | 17,994
Cardiovascular System 6 | 17,957
Digestive Tract 6 | 18,472
Endocrine System 6 | 18,511
Female tissues 6 | 18,646
Nervous System 6 | 18,560
Urinary Tract 6 | 18,443
Liver and Pancreas 5 | 18,135
Male tissues 5 | 17,968
Respiratory system 5 | 17,483
Skin and soft tissues 5 | 18,114

Target Family

Non-IDG 6 | 11,969

Grant Application

5R01AR048615-10 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cofilin-1 CFL1 Tbio Non-IDG -3.08440 1212.2 597
Profilin-3 PFN3 Tdark Non-IDG -0.89066 8.44 8
WD repeat-containing protein 1 WDR1 Tbio Non-IDG -1.61359 43.3 85
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.11585 140.7 401
Destrin DSTN Tbio Non-IDG -2.12930 129.1 190
Actin-related protein T1 ACTRT1 Tdark Non-IDG 0.12 0.83 55